Colon in acute intestinal infection.
The colon is actively implicated in intestinal infections not only as a target of enteric pathogens and their products but also as a target organ for treatment. In the presence of diarrhea, both of osmotic and secretory nature, the colon reacts with homeostatic mechanisms to increase ion absorption. These mechanisms can be effectively exploited to decrease fluid discharge. A model of intestinal infections using rotavirus (RV) in colonic cells was set up and used to define a dual model of secretory and osmotic diarrhea in sequence. Using this model, antidiarrheal drugs were tested, namely zinc and the enkephalinase inhibitor racecadotril. Zinc was able to decrease the enterotoxic activity responsible for secretory diarrhea. It also inhibited the cytotoxic effect of RV. The mechanism of zinc was related at least in part to the activation of MAPK activity, but also a direct antiviral effect was observed. Racecadotril showed a potent and selective inhibition of active secretion, being particularly effective in the first phase of RV diarrhea. The use of drugs active at the colonic level, therefore, offers effective options to treat intestinal infections in childhood. In addition, the colon is the natural site of colonic microflora, a target of probiotic therapy, which is the first line of approach recommended by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition to treat infectious diarrhea.
Guarino
Alfredo
A
Department of Paediatrics, University of Naples "Federico II," Naples, Italy. alfguari@unina.it
Buccigrossi
Vittoria
V
Armellino
Carla
C
D000208:Acute Disease; D000930:Antidiarrheals / Q000627:therapeutic use*; D018938:Caco-2 Cells; D003106:Colon / Q000187:drug effects* / Q000378:metabolism / Q000821:virology; D003967:Diarrhea / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D004353:Drug Evaluation, Preclinical; D005759:Gastroenteritis / Q000188:drug therapy* / Q000378:metabolism / Q000821:virology; D006801:Humans; D007408:Intestinal Absorption / Q000187:drug effects; D012400:Rotavirus Infections / Q000188:drug therapy* / Q000378:metabolism; D015244:Thiorphan / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015032:Zinc / Q000627:therapeutic use*
D000930:Antidiarrheals; C049331:racecadotril; D015244:Thiorphan; D015032:Zinc